Trastuzumab (150 mg)

admin — Wed, 18 Feb 2026 10:55:07 +0000

Overview: Tegafur 100 mg and Uracil 224 mg Capsules contain a combination of Tegafur (100 mg) and Uracil (224 mg) and are prescribed as an oral chemotherapy regimen used in the treatment of certain solid tumors including colorectal cancer by enhancing the activity of fluorouracil and inhibiting cancer cell growth. Key Benefits: – Combination therapy to increase fluorouracil efficacy against cancer cells – Oral dosing for convenient outpatient treatment – Used in colorectal and other solid tumor protocols Composition: Tegafur (100 mg) + Uracil (224 mg) How It Works: Tegafur is a prodrug of 5-fluorouracil (5-FU), and when combined with Uracil, it promotes sustained levels of 5-FU by inhibiting its degradation, leading to enhanced antitumor activity and cancer cell death. Usage Instructions: – Take exactly as directed by your oncologist – Swallow the capsule whole with water, usually with food – Do not crush or chew the capsule Side Effects: – Nausea, vomiting, diarrhea – Fatigue, mouth sores – Low blood counts increasing infection risk Precautions: – Regular blood count and liver/kidney monitoring is required during treatment – Avoid use during pregnancy and breastfeeding unless advised by a physician – Inform your doctor of all current medications Storage Instructions: – Store below 30°C in a cool, dry place away from moisture and light Manufacturer: Therapy Medicines Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

tegafur and uracil capsule – Globalstar International

Trastuzumab (150 mg)